Page last updated: 2024-08-26

enkephalinamide-met, ala(2)- and Disease Models, Animal

enkephalinamide-met, ala(2)- has been researched along with Disease Models, Animal in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schneider, JS; Schroeder, JA1
Peets, JM; Pomeranz, B; Power, C1

Other Studies

2 other study(ies) available for enkephalinamide-met, ala(2)- and Disease Models, Animal

ArticleYear
GABA-opioid interactions in the globus pallidus: [D-Ala2]-Met-enkephalinamide attenuates potassium-evoked GABA release after nigrostriatal lesion.
    Journal of neurochemistry, 2002, Volume: 82, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Cats; Disease Models, Animal; Enkephalin, Methionine; Extracellular Space; gamma-Aminobutyric Acid; Globus Pallidus; Male; Microdialysis; Naloxone; Narcotic Antagonists; Parkinsonian Disorders; Potassium; Recovery of Function

2002
Long latency spinal cord dorsum potential; suppression by intrathecal morphine and enkephalin analog.
    Brain research, 1984, Jun-25, Volume: 304, Issue:2

    Topics: Analgesics; Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Enkephalin, Methionine; Evoked Potentials; Injections, Spinal; Male; Morphine; Pain; Rats; Rats, Inbred Strains; Spinal Cord

1984